BIOSPAIN 2026

BIOSPAIN 2026

The leading biotechnology event in Southern Europe BIOSPAIN 2026 will be celebrated annually as of this year. This edition will be held in the Bilbao Exhibtion Centre from 29th September to 1st October 2026.

The event gathers companies, investors, institutions and professionals from across the global biotech ecosystem

The official BIOSPAIN 2026 website is now live, and delegate registration is open, along with the sale of exhibition spaces. Companies interested in showcasing their capabilities, strengthening their visibility and connecting with key stakeholders can now secure their booth and register attendees at the discounted early bird rates.

Last year’s edition confirmed the scale and impact of BIOSPAIN, with 2,400 registered attendees from 34 countries , +1,000 organisations, 140 investors from 76 diferent investmet firms, and 4,500 one-to-one meetings through the partnering platform.

BIOSPAIN 2026 will once again combine:

  • An international partnering platform with 30 minute on-site meetings.
  • A high-level conference agenda covering science, investment and innovation.
  • Multiple visibility and sponsorship opportunities, tailored to different strategic objectives.
  • Talent Day, a dedicated space connecting companies with biotech professionals and future talent.
  • Networking events where we combine fun with business.

Please, stay tuned for more information on the programme, speakers and activities which will be released in the coming months.

Register early and secure your place at BIOSPAIN 2026!

See you in Bilbao!


BioRN members receive a 10 % discount on ticket prices.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp